232 related articles for article (PubMed ID: 20808934)
1. Overexpression of inosine 5'-monophosphate dehydrogenase type II mediates chemoresistance to human osteosarcoma cells.
Fellenberg J; Kunz P; Sähr H; Depeweg D
PLoS One; 2010 Aug; 5(8):e12179. PubMed ID: 20808934
[TBL] [Abstract][Full Text] [Related]
2. IMPDH2 mediate radioresistance and chemoresistance in osteosarcoma cells.
Li HX; Meng QP; Liu W; Li YG; Zhang HM; Bao FC; Song LL; Li HJ
Eur Rev Med Pharmacol Sci; 2014 Oct; 18(20):3038-44. PubMed ID: 25392102
[TBL] [Abstract][Full Text] [Related]
3. Wnt/β-catenin signalling activates IMPDH2-mediated purine metabolism to facilitate oxaliplatin resistance by inhibiting caspase-dependent apoptosis in colorectal cancer.
Huang Y; Chan S; Chen S; Liu X; Li M; Zheng L; Dong Z; Yang Z; Liu Z; Zhou D; Zhang X; Zhang B
J Transl Med; 2024 Feb; 22(1):133. PubMed ID: 38310229
[TBL] [Abstract][Full Text] [Related]
4. Oxymatrine induces apoptosis in human cervical cancer cells through guanine nucleotide depletion.
Li M; Su BS; Chang LH; Gao Q; Chen KL; An P; Huang C; Yang J; Li ZF
Anticancer Drugs; 2014 Feb; 25(2):161-73. PubMed ID: 24231526
[TBL] [Abstract][Full Text] [Related]
5. Identification of drug-regulated genes in osteosarcoma cells.
Fellenberg J; Dechant MJ; Ewerbeck V; Mau H
Int J Cancer; 2003 Jul; 105(5):636-43. PubMed ID: 12740912
[TBL] [Abstract][Full Text] [Related]
6. Effect of lncRNA ANRIL knockdown on proliferation and cisplatin chemoresistance of osteosarcoma cells in vitro.
Li G; Zhu Y
Pathol Res Pract; 2019 May; 215(5):931-938. PubMed ID: 30777616
[TBL] [Abstract][Full Text] [Related]
7. LncRNA-SARCC sensitizes osteosarcoma to cisplatin through the miR-143-mediated glycolysis inhibition by targeting Hexokinase 2.
Wen JF; Jiang YQ; Li C; Dai XK; Wu T; Yin WZ
Cancer Biomark; 2020; 28(2):231-246. PubMed ID: 32508321
[TBL] [Abstract][Full Text] [Related]
8. Mycophenolic acid inhibits oleic acid-induced mesangial cell activation through both cellular reactive oxygen species and inosine monophosphate dehydrogenase 2 pathways.
Huh KH; Ahn HJ; Park J; Ju MK; Song JS; Kim MS; Kim SI; Kim YS
Pediatr Nephrol; 2009 Apr; 24(4):737-45. PubMed ID: 19093139
[TBL] [Abstract][Full Text] [Related]
9. microRNA-143 is associated with the survival of ALDH1+CD133+ osteosarcoma cells and the chemoresistance of osteosarcoma.
Zhou J; Wu S; Chen Y; Zhao J; Zhang K; Wang J; Chen S
Exp Biol Med (Maywood); 2015 Jul; 240(7):867-75. PubMed ID: 25576341
[TBL] [Abstract][Full Text] [Related]
10. A novel variant L263F in human inosine 5'-monophosphate dehydrogenase 2 is associated with diminished enzyme activity.
Wang J; Zeevi A; Webber S; Girnita DM; Addonizio L; Selby R; Hutchinson IV; Burckart GJ
Pharmacogenet Genomics; 2007 Apr; 17(4):283-90. PubMed ID: 17496727
[TBL] [Abstract][Full Text] [Related]
11. ZNRD1 mediates resistance of gastric cancer cells to methotrexate by regulation of IMPDH2 and Bcl-2.
Hong L; Qiao T; Han Y; Han S; Zhang X; Lin T; Gao J; Zhao P; Chen Z; Fan D
Biochem Cell Biol; 2006 Apr; 84(2):199-206. PubMed ID: 16609701
[TBL] [Abstract][Full Text] [Related]
12. IMP dehydrogenase basal activity in MOLT-4 human leukaemia cells is altered by mycophenolic acid and 6-thioguanosine.
Vethe NT; Bremer S; Bergan S
Scand J Clin Lab Invest; 2008; 68(4):277-85. PubMed ID: 18609073
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenetics of the mycophenolic acid targets inosine monophosphate dehydrogenases IMPDH1 and IMPDH2: gene sequence variation and functional genomics.
Wu TY; Peng Y; Pelleymounter LL; Moon I; Eckloff BW; Wieben ED; Yee VC; Weinshilboum RM
Br J Pharmacol; 2010 Dec; 161(7):1584-98. PubMed ID: 20718729
[TBL] [Abstract][Full Text] [Related]
14. Functional and biological analysis of Bcl-xL expression in human osteosarcoma.
Wang ZX; Yang JS; Pan X; Wang JR; Li J; Yin YM; De W
Bone; 2010 Aug; 47(2):445-54. PubMed ID: 20580954
[TBL] [Abstract][Full Text] [Related]
15. IMPDH2 and HPRT expression and a prognostic significance in preoperative and postoperative patients with osteosarcoma.
Chaiyawat P; Phanphaisarn A; Sirikaew N; Klangjorhor J; Thepbundit V; Teeyakasem P; Phinyo P; Pruksakorn D; Settakorn J
Sci Rep; 2021 May; 11(1):10887. PubMed ID: 34035425
[TBL] [Abstract][Full Text] [Related]
16. The role of IMP dehydrogenase 2 in Inauhzin-induced ribosomal stress.
Zhang Q; Zhou X; Wu R; Mosley A; Zeng SX; Xing Z; Lu H
Elife; 2014 Oct; 3():. PubMed ID: 25347121
[TBL] [Abstract][Full Text] [Related]
17. HSP90AA1-mediated autophagy promotes drug resistance in osteosarcoma.
Xiao X; Wang W; Li Y; Yang D; Li X; Shen C; Liu Y; Ke X; Guo S; Guo Z
J Exp Clin Cancer Res; 2018 Aug; 37(1):201. PubMed ID: 30153855
[TBL] [Abstract][Full Text] [Related]
18. An inosine 5'-monophosphate dehydrogenase 2 single-nucleotide polymorphism impairs the effect of mycophenolic acid.
Winnicki W; Weigel G; Sunder-Plassmann G; Bajari T; Winter B; Herkner H; Sengoelge G
Pharmacogenomics J; 2010 Feb; 10(1):70-6. PubMed ID: 19770842
[TBL] [Abstract][Full Text] [Related]
19. PTBP1 modulates osteosarcoma chemoresistance to cisplatin by regulating the expression of the copper transporter SLC31A1.
Cheng C; Ding Q; Zhang Z; Wang S; Zhong B; Huang X; Shao Z
J Cell Mol Med; 2020 May; 24(9):5274-5289. PubMed ID: 32207235
[TBL] [Abstract][Full Text] [Related]
20. IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways.
Duan S; Huang W; Liu X; Liu X; Chen N; Xu Q; Hu Y; Song W; Zhou J
J Exp Clin Cancer Res; 2018 Dec; 37(1):304. PubMed ID: 30518405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
